BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Selvam P, El-Sherbiny IM, Smyth HD. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers. J Aerosol Med Pulm Drug Deliv 2011;24:25-34. [PMID: 20961166 DOI: 10.1089/jamp.2010.0830] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Alzanbaki H, Moretti M, Hauser CAE. Engineered Microgels-Their Manufacturing and Biomedical Applications. Micromachines (Basel) 2021;12:45. [PMID: 33401474 DOI: 10.3390/mi12010045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Du J, El-Sherbiny IM, Smyth HD. Swellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery. AAPS PharmSciTech 2014;15:1535-44. [PMID: 25079240 DOI: 10.1208/s12249-014-0176-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
3 Secret E, Kelly SJ, Crannell KE, Andrew JS. Enzyme-Responsive Hydrogel Microparticles for Pulmonary Drug Delivery. ACS Appl Mater Interfaces 2014;6:10313-21. [DOI: 10.1021/am501754s] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
4 Subramani PA, Panati K, Narala VR. Curcumin Nanotechnologies and Its Anticancer Activity. Nutr Cancer 2017;69:381-93. [PMID: 28287321 DOI: 10.1080/01635581.2017.1285405] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
5 Daly AC, Riley L, Segura T, Burdick JA. Hydrogel microparticles for biomedical applications. Nat Rev Mater 2020;5:20-43. [PMID: 34123409 DOI: 10.1038/s41578-019-0148-6] [Cited by in Crossref: 130] [Cited by in F6Publishing: 69] [Article Influence: 43.3] [Reference Citation Analysis]
6 El-Sherbiny IM, Smyth HD. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. Mol Pharm 2012;9:269-80. [PMID: 22136259 DOI: 10.1021/mp200351y] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 6.7] [Reference Citation Analysis]
7 Guo Y, Bera H, Shi C, Zhang L, Cun D, Yang M. Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines. Acta Pharm Sin B 2021;11:2565-84. [PMID: 34522598 DOI: 10.1016/j.apsb.2021.05.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
8 Arya G, Das M, Sahoo SK. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomedicine & Pharmacotherapy 2018;102:555-66. [DOI: 10.1016/j.biopha.2018.03.101] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 12.8] [Reference Citation Analysis]
9 Du J, Du P, Smyth HD. Hydrogels for controlled pulmonary delivery. Ther Deliv 2013;4:1293-305. [PMID: 24116913 DOI: 10.4155/tde.13.90] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
10 Myrdal PB, Sheth P, Stein SW. Advances in metered dose inhaler technology: formulation development. AAPS PharmSciTech 2014;15:434-55. [PMID: 24452499 DOI: 10.1208/s12249-013-0063-x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 69] [Article Influence: 11.8] [Reference Citation Analysis]
11 Stocke NA, Arnold SM, Hilt JZ. Responsive Hydrogel Nanoparticles for Pulmonary Delivery. J Drug Deliv Sci Technol 2015;29:143-51. [PMID: 26339298 DOI: 10.1016/j.jddst.2015.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
12 Ni R, Zhao J, Liu Q, Liang Z, Muenster U, Mao S. Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery. European Journal of Pharmaceutical Sciences 2017;99:137-46. [DOI: 10.1016/j.ejps.2016.12.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 7.2] [Reference Citation Analysis]
13 Secret E, Crannell KE, Kelly SJ, Villancio-Wolter M, Andrew JS. Matrix metalloproteinase-sensitive hydrogel microparticles for pulmonary drug delivery of small molecule drugs or proteins. J Mater Chem B 2015;3:5629-34. [PMID: 32262533 DOI: 10.1039/c5tb00443h] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
14 Myrdal PB, Sheth P, Stein SW. Advances in metered dose inhaler technology: formulation development. AAPS PharmSciTech 2014;15:434-55. [PMID: 24452499 DOI: 10.1208/s12249-013-0063-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC. Therapeutic Applications of Curcumin Nanoformulations. AAPS J 2015;17:1341-56. [PMID: 26335307 DOI: 10.1208/s12248-015-9811-z] [Cited by in Crossref: 136] [Cited by in F6Publishing: 122] [Article Influence: 19.4] [Reference Citation Analysis]
16 Ehtezazi T, Davies MJ, Seton L, Morgan MN, Ross S, Martin GD, Hutchings IM. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs. Drug Dev Ind Pharm 2015;41:279-91. [PMID: 24252108 DOI: 10.3109/03639045.2013.858741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]